Ou SI, Lin HM, Hong JL, Yin Y, et al. Comparative effectiveness of mobocertinib and standard of care in patients with NSCLC with EGFR exon 20 insertion mutations: An indirect comparison. Lung Cancer 2023;179:107186.
PMID: 37075617